MedPath

A Clinical Study: the Antibacterial Effect of Insoluble Antibacterial Nanoparticles (IABN) Incorporated in Dental Materials for Root Canal Treatment

Phase 2
Conditions
Endodontic Treatment
Irreversible Pulpitis
Health Pulp
Infected Pulp
Interventions
Device: IABN
Registration Number
NCT01167985
Lead Sponsor
Hadassah Medical Organization
Brief Summary

The effect of Antibacterial Nanoparticles, Incorporated in root canal sealer material and in provisional restoration is going to be examined. Two different tests are planned: (1) clinical and radiological evaluation of root canal sealer.(2) An evaluation in the laboratory the efficacy of provisional restoration during root canal treatment.We assume, based on our previous laboratory studies that show antibacterial properties, that the incorporation of the nanoparticels will improve the treatment outcome.

Detailed Description

1. patients with molar teeth diagnosed with healthy pulp or irreversible pulpitis, and need root canal treatment, will be asked to participate in the study. After cleaning the teeth following a standard protocol, a sterile cotton wool will be placed in the pulp chamber. provisional restoration with (test group-40 patients) and without (control group- 40 patients) nanoparticles will seal the teeth between apointments. After a month the cotton wool will be taken out and tansferred to the laboratory. The root canal treatment will continue following the standard protocol.

2. patients with single canal teeth diagnosed with infected pulp and periapical lesion, and need root canal treatment, will be asked to participate in the study. Two study group (40 patients on each group) will have their canal sealed with a two types of endodontic sealers each + the nanoparticles. The control group (40 patients) will have their canal sealed with the conventional sealer alone. The patients will be invited to 4 follow ups: 2 weeks, 3 months, 6 months and 1 year during which a clinical and radiological examinations will be performed.While preparing the post, a small example of the sealer will be taken to a test in the lab.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. Needs root canal treatment
  2. For the provisional restoration- molar teeth with class II restoration
  3. For the provisional restoration-healty/ uninfected teeth
  4. For the root canal sealer- single root canal
  5. For root canal sealer-infected teeth
Exclusion Criteria
  1. systemic health problems
  2. Pregnant women
  3. The use of antiseptic mouth rinse or antibiotic Up to 2 weeks before the beginning of study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Root canal sealer group+ IABNIABNDevice: alkylated polyethylenimine nanoparticles antibacterial evaluation
Provisional restoration material+ IABNIABNDevice: alkylated polyethylenimine nanoparticles antibacterial evaluation
Experimental- Different root canal sealer+ IABNIABNDevice: alkylated polyethylenimine nanoparticles antibacterial evaluation
Primary Outcome Measures
NameTimeMethod
In vitro evaluationOne month for provisional restoration.

clinical and radiological evaluation of the radiolucent periapical lesion, for the root canal sealer. As for the provisional restoration, in vitro assesment of bacterial growth.

Secondary Outcome Measures
NameTimeMethod
Radiological evaluation of the root canal sealer1 year for the root canal sealer.

clinical and radiological evaluation of the radiolucent periapical lesion, for the root canal sealer. As for the provisional restoration, in vitro assesment of bacterial growth.

Clinical and in vitro evaluation of the root canal sealer1 year for the root canal sealer.

clinical and radiological evaluation of the radiolucent periapical lesion, for the root canal sealer. As for the provisional restoration, in vitro assesment of bacterial growth.While preparing the post, a sample of the sealer will be taken to evaluation in the lab.

Trial Locations

Locations (1)

Hadassah Medical Organization

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath